Telehealth is not the only route to a GLP-1 prescription, and by late 2026 it is not automatically the cheapest one either. Brand-name self-pay pricing has fallen far enough that the comparison is genuinely competitive for the first time.
Key Takeaways
- Manufacturer self-pay programs have brought brand-name pricing down to levels that compete with compounded telehealth.
- In-person weight clinics typically charge a visit or program fee on top of medication cost.
- Telehealth's advantage is largely in access and convenience rather than a large price gap on brand-name products.
- Compounded telehealth remains the lowest-cost route on published rates, with the trade-off that the product is not FDA-approved.
- Insurance coverage, where it exists, changes the ranking completely — check it before comparing cash prices.
| Channel | Medication cost | Additional fees | Product type |
|---|---|---|---|
| Compounded telehealth | $99–$399/mo depending on drug, format and provider | Usually bundled; shipping sometimes separate | Compounded — not FDA-approved |
| Brand-name via manufacturer self-pay | Reference points around $199/mo for Wegovy injection; Zepbound vials from $299/mo | None beyond the prescription source | FDA-approved |
| Brand-name via telehealth marketplace | Brand price plus a visit fee | Per-visit consultation fee | FDA-approved |
| In-person weight clinic | Varies widely; often a program fee plus medication | Visit fees, program fees, sometimes required labs | Varies |
| Primary care plus retail pharmacy | Insurance-dependent; cash price otherwise | Copay or visit cost | FDA-approved |
What changed in brand-name pricing
Manufacturer direct-pay programs materially lowered cash prices for brand-name GLP-1s over 2025 and 2026. The practical effect is that the price gap between an FDA-approved product and a compounded preparation narrowed considerably, and at some dose tiers it closed.
That reframes the decision. When brand-name cost several times more, compounded medication was the only accessible option for many people. When the gap is a hundred dollars a month, the FDA-approval difference is worth weighing on its own terms rather than being priced out of consideration.
Sesame Care
Brand-name only- Marketplace model — you book a licensed clinician and pay per visit
- Brand-name FDA-approved medications only; Sesame does not offer compounded GLP-1s
- Useful reference point against NovoCare and LillyDirect self-pay pricing
Because Sesame routes to brand-name products only, it is the cleanest apples-to-apples comparison against compounded pricing elsewhere in this table.
What the in-person clinic actually offers
Local weight clinics generally cost more, and the reasons are not all overhead. In-person examination, on-site labs, direct handling of complications, and continuity with a clinician who knows your case are real services that a questionnaire cannot replicate.
Whether they are worth the premium depends on your situation. A straightforward case with no complicating history probably does not need them. A complex medication list, a history that requires careful review, or a plan to stay on treatment for years are all arguments for the more expensive channel.
Wellorithm
Lowest published oral price- Compounded tablet format — no needles, no cold chain
- Publishes per-format pricing rather than bundling everything into one plan
- Injectable options also offered
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
MadeMed (Injectable Semaglutide)
Injectable- Monthly and quarterly billing options
- L-carnitine included in the injectable formulation
- Membership program available for refill discounts
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
Found Health
4-week billing cycle- Bills in 4-week cycles, not calendar months — 13 cycles a year, not 12
- Behavior-change coaching bundled with the medication track
- Dissolvable tablet format
A 4-week cycle means your true annual cost is 13 × the quoted price. Worth doing the multiplication before comparing against a monthly-billed competitor.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
Where telehealth still clearly wins
Access. No appointment wait, no travel, no time off work. For anyone outside a metro area this is not a convenience argument — it is the difference between treatment and no treatment.
Lowest published cash prices. Compounded oral and sublingual rates in the $99–$150 range have no equivalent in any other channel.
No coverage negotiation. Cash-pay telehealth sidesteps prior authorization entirely. Whether that is a feature or a symptom depends on your view of the coverage system, but it is a real practical difference.
Telos Rx (Tirzepatide)
Flat pricing by plan length- Price is flat regardless of dose tier once your plan is set
- 12-month plan carries the lowest monthly rate; 1-month is the highest
- Cancel anytime; FSA/HSA accepted
Telos publishes plan-length pricing rather than dose-tier pricing, so the number you see at signup depends on the commitment you choose, not the milligrams you take.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
SHED
Multi-format- Carries brand-name options alongside compounded: Wegovy pen $199, oral Wegovy pill $149, Zepbound $349 plus a $99 membership
- 120-day results guarantee (terms updated June 10, 2026)
- Multi-month terms convert to a different ongoing rate — read the conversion language
Price-jump disclosure: SHED's tirzepatide pricing increases to $399/mo once you reach the 7.5 mg maintenance tier. Budget for the higher number, not the entry number.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
Frequently Asked Questions
Is telehealth cheaper than a local clinic?
On published cash prices, generally yes — in-person clinics typically add visit or program fees. Insurance coverage can reverse the comparison entirely.
Is brand-name now competitive with compounded?
Manufacturer self-pay pricing has narrowed the gap considerably. Compounded remains lower on published rates, particularly for oral formats, but the difference is much smaller than it was.
Does insurance cover any of this?
Coverage for weight-management indications varies widely by plan and has been volatile. Check your specific plan's formulary and prior-authorization requirements before assuming either way.
Can you use a telehealth prescription at a local pharmacy?
For brand-name products prescribed through a telehealth marketplace, generally yes. Compounded preparations come from the compounding pharmacy the provider works with, not from a retail pharmacy.